• Medical_Professionals
• Medical_students
• Nurses

We are proud to announce and invite you to the 13th European Headache Federation Congress that will be held in the Athens Concert Hall, “Megaron”, on May 30th - June 1st 2019.

Committed to the European Headache Federation mission of Science and Education through Renovation, this European Congress aims to improve the life of those affected by headache in Europe by giving light to the new scientific evidence on therapeutics, comorbidities and pathogenesis of headache. Amidst a plethora of new migraine treatments that have never reached this density, power and precision before, new alliances linking efforts guided by both sufferers and therapists lead to astonishing horizons. The Congress is focused on the detailed message identification and clarification of all novel treatments including those targeting the CGRP and 5- HT1F pathways, treatments targeting the PACAP signaling as well as neurostimulation trials. All the aspects of headache nosology will be covered with emphasis on the patient’s journey within this spectrum.

Athens is the capital and largest city of Greece. The birthplace of philosophy, democracy and drama, an open-air museum of world-class cultural heritage attractions; but Athens is also a contemporary metropolis with an urban personality. A city where the sun shines 290 days a year, where there are hotels and restaurants to suit every taste, budget and requirement and only in a short flight away from most European cities.

We lean on your support and active participation in order to pave the way of EHF to the future. Bringing your expertise to the Athens Congress can guarantee that the 13th European Headache Federation Congress will be one of the leading headache meetings in Europe. 

Looking forward to meeting you in Athens,

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Abstracts must be submitted via the website www.ehf2019.com*

*Submissions forwarded by e-mail, fax, post or courier will not be accepted.

If the Abstract is constructed by more than one author, please include all of them in the credits.

Kindly note that in order to submit and present your Abstract, at least one of the authors must be registered to the Conference.

A few general rules for preparing abstracts:

Abstracts must be written in English.

Text copied from another document should be written in Calibri; special characters should be included during submission through the special pull-down system.

The title should be written in standard sentence style with lower case letters (except first word, names, human gene names [always upper case letters & italics], etc.)

The abstract text must not exceed 2000 characters, including spaces and headings.

Drugs must be mentioned by generic names, not trade names.

Non-standard abbreviations must be defined in the text.

Submitted abstracts must provide results and not announcements; stating that “Findings will be discussed…” or similar is not acceptable.

Abstracts should have the following headings:

Background

Case Study / Methods (delete as appropriate)

Results

Discussion

Abstract submission deadline 2019-05-30

PCO ONE TO ONE SA ,

16, Nikis Str. 105 57 Athens, Greece

T +30 210 7254383-5 F +30 210 7254384 E info@ehf2019.com

www.ehf2019.com

Gold Sponsors

Sponsors

Supporters

PCO ONE TO ONE SA ,

16, Nikis Str. 105 57 Athens, Greece

T +30 210 7254383-5 F +30 210 7254384 E info@ehf2019.com

www.ehf2019.com